Article info

Download PDFPDF

Original research
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment

Authors

  • Jennifer C Davies Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Angela Midgley Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Emil Carlsson Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Sean Donohue Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Ian N Bruce Arc Epidemiology Unit, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Michael W Beresford Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Christian M Hedrich Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Christian Hedrich; christian.hedrich{at}liverpool.ac.uk
View Full Text

Citation

Davies JC, Midgley A, Carlsson E, et al
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment

Publication history

  • Received April 1, 2020
  • Revision received May 27, 2020
  • Accepted June 7, 2020
  • First published July 28, 2020.
Online issue publication 
July 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.